Testing effectiveness (Phase 2)WithdrawnNCT03187691
What this trial is testing
Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia
Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Matinas BioPharma Nanotechnologies, Inc.